glp 2 vs tirzepatide Management of type diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis | Diabetologia Retatrutide vs. Tirzepatide: The Next-Gen
Description
That means it targets GLP-1 and GIP receptors in your body

We get it, ordering medication online and skipping the doctor's office sounds appealing
Once a cycle has started, refunds are not typically available

Rebound weight gain after stopping tirzepatide is not a failure of willpower

But doing mental math with medication is not ideal, which is why having a reference chart matters

Why it matters: A larger average trial result does not guarantee a better individual choice